For the year ending 2025-12-31, DTIL made $34,264K in revenue. -$45,724K in net income. Net profit margin of -133.45%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Revenue | 34,264 | 68,696 | ||
| Research and development | 54,172 | 59,559 | ||
| General and administrative | 32,240 | 35,299 | ||
| Total operating expenses | 86,412 | 94,858 | ||
| Interest expense | - | 1,782 | ||
| Operating loss | -52,148 | -26,162 | ||
| Loss from equity method investment | -5,284 | -1,084 | ||
| (loss) gain on changes in other fair value adjustments | -2,666 | 258 | ||
| Gain on change in fair value of warrant liability | 11,129 | - | ||
| Interest expense | 1,422 | - | ||
| Interest income | 4,239 | 6,763 | ||
| Loss on disposal of assets | -421 | -436 | ||
| Gain on change in fair value of warrant liability | - | 29,610 | ||
| Impairment charges | 36 | - | ||
| Total other income | 5,539 | 33,329 | ||
| (loss) income from continuing operations | -46,609 | 7,167 | ||
| Gain from discontinued operations | 885 | - | ||
| Net (loss) income | -45,724 | 7,167 | ||
| Basic EPS | -3.56 | 1.05 | ||
| Diluted EPS | -3.56 | 1.04 | ||
| Basic Average Shares | 12,826,078 | 6,832,982 | ||
| Diluted Average Shares | 12,826,078 | 6,883,911 | ||
PRECISION BIOSCIENCES INC (DTIL)
PRECISION BIOSCIENCES INC (DTIL)